#1 anetretry

2023-01-23 14:26:44 : The pace of research and discovery in precision medicine and immunoprevention has been astonishing and includes the following clinical firsts reported in 2015 driver mutations detected in circulating cell free DNA in patients with premalignant lesions lung; clonal hematopoiesis shown to be a premalignant state; molecular selection in chemoprevention randomized controlled trial RCT; oral; striking efficacy in RCT of combination chemoprevention targeting signaling pathway alterations mechanistically linked to germline mutation duodenum; molecular markers for early detection validated for lung cancer and showing promise for pancreatic, liver, and ovarian cancer propecia